Coronado Research

Silver Sponsor

At Coronado Research, we specialise in comprehensive Market Access and HEOR (Health Economics and Outcomes Research) strategies that bridge the gap between innovative therapies and acceptance within healthcare systems. Our experts provide realistic payer solutions to develop meaningful evidence and optimise market access for new assets.

Despite the ever-increasing amount of data being collected as part of the drug development process, much of it is not utilised in decision making. Coronado’s vision, however, is centred on treating the drug development process as a continuum where data from earlier phases is used to inform later stages, serving as the “golden thread”.​ Our team of experts can support you from the earliest stages of drug development through to working with pricing and reimbursement authorities to gain patient access and optimal pricing.

Advances in data and technology are transforming market access and HEOR by enabling more efficient evidence generation and personalised value assessments. Real-world data integration combined with AI-driven analytics provide richer insights into a therapy’s effectiveness, cost-effectiveness, and patient outcomes, helping meet payer demands. These innovations support optimal patient access and better alignment with stakeholder needs.

website